Compare · INM vs TLRY

INM vs TLRY

Side-by-side comparison of InMed Pharmaceuticals Inc. (INM) and Tilray Brands Inc. (TLRY): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both companies sit in the Health Care sector. INM focuses on Biotechnology: Pharmaceutical Preparations, while TLRY focuses on Medicinal Chemicals and Botanical Products.
  • TLRY is the larger of the two at $347.3M, about 40.6x INM ($8.5M).
  • INM has been more active in the news (12 items in the past 4 weeks vs 5 for TLRY).
  • TLRY has more recent analyst coverage (14 ratings vs 1 for INM).
MetricINMTLRY
Company
InMed Pharmaceuticals Inc.
Tilray Brands Inc.
Price
-
-
Market cap
$8.5M
$347.3M
1M return
-
-25.37%
1Y return
-
-77.79%
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Exchange
NASDAQ
NASDAQ
IPO
2018
News (4w)
12
5
Recent ratings
1
14
INM

InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.

TLRY

Tilray Brands Inc.

Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.

Latest INM

Latest TLRY